✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Kwality Pharmaceuticals Ltd.

KPL

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹932 Cr.
P/E
21.47

Kwality Pharmaceuticals Ltd.

  • Kwality Pharma
  • Wanbury
  • Anuh Pharma

FAQs on Kwality Pharmaceuticals Ltd. Shareprice

Kwality Pharma has given better returns compared to its competitors.
Kwality Pharma has grown at ~51.54% over the last 7yrs while peers have grown at a median rate of 25.04%

Kwality Pharma is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Kwality Pharma is 21.09, while 3 year average PE is 25.03.
Also latest EV/EBITDA of Kwality Pharma is 11.62 while 3yr average is 8.13.

View FAQ's On Business

Growth Table

  • Kwality Pharmaceuticals Ltd.
  • Wanbury
  • Anuh Pharma

Balance Sheet

  • Kwality Pharmaceuticals Ltd.
  • Wanbury
  • Anuh Pharma

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Kwality Pharmaceuticals Ltd.
  • Wanbury
  • Anuh Pharma

Cash Flow

  • Kwality Pharmaceuticals Ltd.
  • Wanbury
  • Anuh Pharma

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Kwality Pharmaceuticals Ltd.
  • Wanbury
  • Anuh Pharma

Quarterly Results

  • Kwality Pharmaceuticals Ltd.
  • Wanbury
  • Anuh Pharma

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Kwality Pharmaceuticals Ltd. Financials

Balance sheet of Kwality Pharma is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Kwality Pharma is increasing.
Latest net debt of Kwality Pharma is ₹93.61 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹86.39 Crs.

Yes, profit is increasing.
The profit of Kwality Pharma is ₹43.38 Crs for TTM, ₹39.85 Crs for Mar 2025 and ₹23.8 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Kwality Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech